glp 1 drugs pancreatitis GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes glp 1 agonist side effects

While this effect can be beneficial for glucose control, it raises concerns for co-administered therapies

62 percent said they were constantly thinking about food throughout the day, while 53 percent alleged their thoughts about eating had felt uncontrollable

Guidelines have evolved considerably from routine medication cessation in 2023 to GLP-1 RA continuation with individualised risk assessment in 20242025, illustrating increasing acknowledgment that certain theoretical risks may be underestimated

GLP-1 medications can help because they do not just ask patients to use more willpower

[175] An analysis of events in the US FDA Adverse Event Reporting System suggests an association between several GLP-1 agonists (including semaglutide) and cutaneous reactions, such as dermal hypersensitivity reactions, eosinophilic panniculitis, bullous pemphigoid, and morbilliform drug eruptions